Key Players in the GLP-1 Diabetes Treatment Drugs Market Eli Lilly Sanofi Novo Nordisk Hanmi Pharmaceutical Co Boehringer Ingelheim AstraZeneca Pfizer Inc Teva Pharmaceutical Industries Ltd GlaxoSmithKline (GSK) Ganli Pharmaceuticals Tonghua Dongbao Shanghai Renhui Biopharmaceuticals Co., Ltd
Semaglutide (Ozempic, Wegovy, compounded) Semaglutide has the longest half-life among commonly used GLP-1 medications at approximately seven days
Blauvelt A, Kimball AB, Augustin M, Okubo Y, Witte MM, Capriles CR, Sontag A, Arora V, Osuntokun O, Strober B (2022) Efficacy and safety of mirikizumab in psoriasis: results from a 52-week, double-blind, placebo-controlled, randomized withdrawal, phase III trial (OASIS-1)
BPC-157 works by encouraging new blood vessel formation (angiogenesis), boosting collagen production for healthier connective tissues, and reducing inflammation, thereby assisting in the healing of tendons, ligaments, and muscles